{"id":1945,"date":"2019-11-28T08:00:11","date_gmt":"2019-11-28T07:00:11","guid":{"rendered":"https:\/\/www.ggkmedia.com\/?p=1945"},"modified":"2020-03-30T21:09:00","modified_gmt":"2020-03-30T19:09:00","slug":"double-bond-pharma-rapporterar-positiva-resultat-fran-klinisk-studie-med-inofer","status":"publish","type":"post","link":"https:\/\/www.drugsson.com\/sv\/double-bond-pharma-rapporterar-positiva-resultat-fran-klinisk-studie-med-inofer\/","title":{"rendered":"Double Bond Pharma rapporterar positiva resultat fr\u00e5n klinisk studie med Inofer"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-background-repeat:repeat;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:90px;--awb-padding-bottom:90px;--awb-background-color:#eaf7ff;--awb-border-sizes-top:0px;--awb-border-sizes-bottom:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-padding-top:50px;--awb-padding-right:50px;--awb-padding-bottom:30px;--awb-padding-left:50px;--awb-bg-color:#ffffff;--awb-bg-color-hover:#ffffff;--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><h3>Double Bond Pharma rapporterar positiva resultat fr\u00e5n klinisk studie med Inofer<\/h3>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-padding-top:50px;--awb-padding-right:50px;--awb-padding-bottom:50px;--awb-padding-left:50px;--awb-bg-color:#ffffff;--awb-bg-color-hover:#ffffff;--awb-bg-size:cover;--awb-border-color:#25afb4;--awb-border-bottom:8px;--awb-border-style:solid;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-2\"><p>L\u00e4kemedelsbolaget Double Bond Pharma rapporterar resultaten av en studie som utv\u00e4rderade Inofer, en medicinsk produkt mot j\u00e4rnbrist, hos patienter med hj\u00e4rtsvikt och j\u00e4rnbrist som inte har anemi. Idag rekommenderas att j\u00e4rnbehandling ska ges intraven\u00f6st d\u00e5 patienter med hj\u00e4rtsvikt hittills har ansetts ha ett otillr\u00e4ckligt upptag av oral j\u00e4rnbehandling. I denna pilotstudie hade patienter som fick Inofer, j\u00e4rnsuccinat, oralt ett markant och signifikant f\u00f6rb\u00e4ttrat j\u00e4rnupptag, med f\u00f6rb\u00e4ttrad j\u00e4rnm\u00e4ttnad och f\u00f6rb\u00e4ttrade j\u00e4rnlagering. Det framg\u00e5r av ett pressmeddelande.<\/p>\n<p>I denna studie rekryterades 20 patienter med hj\u00e4rtsvikt och j\u00e4rnbrist, utananemi. Inofer togs oralt tv\u00e5 g\u00e5nger dagligen under minst tre m\u00e5nader. Det prim\u00e4ra m\u00e5let med denna pilotstudie var att unders\u00f6ka j\u00e4rnupptag, m\u00e4ttnad och j\u00e4rnlagering hos dessa patienter. Det andra m\u00e5let var att unders\u00f6ka j\u00e4rnupptaget redan efter sex veckor.<\/p>\n<p>Double Bond Pharma presenterar nu resultaten av den ovann\u00e4mnda kliniska pr\u00f6vningen med Inofer. Analyserna av alla blodprover \u00e4r klara och resultaten visar att Inofer som gavs tv\u00e5 g\u00e5nger dagligen f\u00f6rb\u00e4ttrade markant och signifikant j\u00e4rnm\u00e4ttnad och j\u00e4rnlager hos patienterna. B\u00e5de den prim\u00e4ra och det sekund\u00e4ra m\u00e5len \u00e4r s\u00e5ledes uppn\u00e5dda. Inofer tolererades v\u00e4l. Den patientgrupp som fick Inofer upplevde n\u00e5gra v\u00e4lk\u00e4nda och milda biverkningar av oral j\u00e4rnterapi.<\/p>\n<p>Sammantaget indikerar resultaten av pilotstudien att Inofer som ges tv\u00e5 g\u00e5nger dagligen kan anv\u00e4ndas f\u00f6r behandling av j\u00e4rnbrist hos patienter med hj\u00e4rtsvikt utananemi.<\/p>\n<p>Dessa resultat motiverar ytterligare klinisk utv\u00e4rdering av produkten. Resultaten av den kliniska studien kommer att presenteras av f\u00f6rfattarna p\u00e5 n\u00e4sta relevanta vetenskapliga konferens.<\/p>\n<p><a href=\"https:\/\/www.spotlightstockmarket.com\/sv\/bolag\/irabout\/?companyid=1490\" target=\"_blank\" rel=\"noopener noreferrer\">L\u00e4s mer<\/a> om Double Bond Pharmaceutical International AB<\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-3\"><h4>Nyhetsk\u00e4lla<\/h4>\n<\/div><div class=\"fusion-text fusion-text-4\"><p><a href=\"https:\/\/www.spotlightstockmarket.com\/sv\/market-overview\/nyheter\/nyhets-artikel\/?id=26327&amp;publisher=371\" target=\"_blank\" rel=\"noopener noreferrer\">Spotlight<\/a><\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-sharing-box fusion-sharing-box-1 boxed-icons has-taglines layout-floated layout-medium-floated layout-small-floated\" style=\"background-color:#f6f6f6;--awb-layout:row;--awb-alignment-small:space-between;\" data-title=\"Double Bond Pharma rapporterar positiva resultat fr\u00e5n klinisk studie med Inofer\" data-description=\"Double Bond Pharma rapporterar positiva resultat fr\u00e5n klinisk studie med Inofer    L\u00e4kemedelsbolaget Double Bond Pharma rapporterar resultaten av en studie som utv\u00e4rderade Inofer, en medicinsk produkt mot j\u00e4rnbrist, hos patienter med hj\u00e4rtsvikt och j\u00e4rnbrist som inte har anemi. Idag rekommenderas att j\u00e4rnbehandling ska ges intraven\u00f6st d\u00e5 patienter med\" data-link=\"https:\/\/www.drugsson.com\/sv\/double-bond-pharma-rapporterar-positiva-resultat-fran-klinisk-studie-med-inofer\/\"><h4 class=\"tagline\" style=\"color:#4c5166;\">Dela inl\u00e4gget<\/h4><div class=\"fusion-social-networks sharingbox-shortcode-icon-wrapper sharingbox-shortcode-icon-wrapper-1 boxed-icons\"><span><a href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fdouble-bond-pharma-rapporterar-positiva-resultat-fran-klinisk-studie-med-inofer%2F&amp;t=Double%20Bond%20Pharma%20rapporterar%20positiva%20resultat%20fr%C3%A5n%20klinisk%20studie%20med%20Inofer\" target=\"_blank\" rel=\"noreferrer\" title=\"Facebook\" aria-label=\"Facebook\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"Facebook\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-facebook awb-icon-facebook\" style=\"color:#ffffff;background-color:#3b5998;border-color:#3b5998;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/x.com\/intent\/post?text=Double%20Bond%20Pharma%20rapporterar%20positiva%20resultat%20fr%C3%A5n%20klinisk%20studie%20med%20Inofer&amp;url=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fdouble-bond-pharma-rapporterar-positiva-resultat-fran-klinisk-studie-med-inofer%2F\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"X\" aria-label=\"X\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"X\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-twitter awb-icon-twitter\" style=\"color:#ffffff;background-color:#000000;border-color:#000000;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&amp;url=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fdouble-bond-pharma-rapporterar-positiva-resultat-fran-klinisk-studie-med-inofer%2F&amp;title=Double%20Bond%20Pharma%20rapporterar%20positiva%20resultat%20fr%C3%A5n%20klinisk%20studie%20med%20Inofer&amp;summary=Double%20Bond%20Pharma%20rapporterar%20positiva%20resultat%20fr%C3%A5n%20klinisk%20studie%20med%20Inofer%20%20%20%20%20%20%20%0D%0A%0D%0AL%C3%A4kemedelsbolaget%20Double%20Bond%20Pharma%20rapporterar%20resultaten%20av%20en%20studie%20som%20utv%C3%A4rderade%20Inofer%2C%20en%20medicinsk%20produkt%20mot%20j%C3%A4rnbrist%2C%20hos%20patienter%20med%20hj%C3%A4rtsvikt%20och%20j%C3%A4rnbrist%20som%20inte%20har%20anemi.%20Idag%20rekommenderas%20att%20j%C3%A4rnbehandling%20ska%20ges%20intraven%C3%B6st%20d%C3%A5%20patienter%20med\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"LinkedIn\" aria-label=\"LinkedIn\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"LinkedIn\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-linkedin awb-icon-linkedin\" style=\"color:#ffffff;background-color:#0077b5;border-color:#0077b5;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,4],"tags":[],"_links":{"self":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/1945"}],"collection":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/comments?post=1945"}],"version-history":[{"count":2,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/1945\/revisions"}],"predecessor-version":[{"id":1947,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/1945\/revisions\/1947"}],"wp:attachment":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/media?parent=1945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/categories?post=1945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/tags?post=1945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}